‘Chilling, dramatic, horrific’: Fred Hutch leader warns of harm from Trump’s proposed funding cuts
Leaders at the Fred Hutch Cancer Center said the Trump administration's proposed NIH funding cuts would be "chilling, ...
Becker's Hospital Review7h
Fred Hutch Cancer Center to invest $13.5M in cybersecurity after hack
Seattle's Fred Hutch Cancer Center to invest $13.5 million in cybersecurity upgrades following 2023 data breach settlement. Class members may receive up to $5K.
Fred Hutch ending DEI initiatives in response to Trump orders
According to an email to staff, Fred Hutch had to immediately end its DEI programs "due to several significant federal grant ...
The Stranger6d
Fred Hutch Cancer Center to Acquiesce to Trump Order, End DEI Efforts
Fred Huch Cancer Center told staff on Thursday that it will dismantle its diversity, equity, and inclusion (DEI) programs to ...
Fred Hutch ends DEI initiatives in compliance with Trump’s order
Fred Hutchinson Cancer Center is ending its diversity, equity, inclusion (DEI) initiatives to comply with President Donald ...
Fred Hutch13d
Novel regimen greatly reduced chronic GVHD in phase 2 study at Fred Hutch
A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...
MyNorthwest.com6d
Fred Hutchinson Cancer Center ends DEI programs
Fred Hutchinson Cancer Center will end its DEI programs to retain federal funding, raising concerns about diversity, equity, ...
The Spokesman-Review7d
Fred Hutch ending DEI initiatives in response to Trump orders
Fred Hutchinson Cancer Center is ending diversity, equity and inclusion initiatives due to President Donald Trump’s executive order ending federal funding to agencies that have DEI programs ...
What’s at stake for Washington’s flagship research institutions in the legal battle over NIH funding
The fight unfolding over the Trump administration's sudden limit on NIH grant funding could slash budgets for Washington's ...
Fred Hutch13d
Skin in the game: Changing the story of Merkel cell carcinoma
Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...